JN Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


J Neurophysiol (July 1, 2009). doi:10.1152/jn.00294.2009
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
102/3/1358    most recent
00294.2009v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Thorn Perez, C.
Right arrow Articles by Grillner, S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thorn Perez, C.
Right arrow Articles by Grillner, S.
Submitted on April 2, 2009
Revised on June 12, 2009
Accepted on June 28, 2009

Endocannabinoids mediate tachykinin induced effects in the lamprey locomotor network

Carolina Thorn Perez1, Russell H Hill1, Abdeljabbar El Manira1, and Sten Grillner1*

1 Karolinska Institutet

* To whom correspondence should be addressed. E-mail: sten.grillner{at}ki.se.

The spinal network underlying locomotion in lamprey is composed of excitatory and inhibitory interneurons mediating fast ionotropic action. In addition, several modulator systems are activated as locomotion is initiated, including the tachykinin system and the mGluR1 receptors, the latter operating partially via the endocannabinoid system. The effects of mGluR1 agonists and tachykinins resemble each other. Like mGluR1 agonists, the tachykinin substance P, accelerates the burst rate and reduces the crossed inhibition in an activity-dependent fashion. The present study therefore explores if tachykinins also utilize the endocannabinoid system to modulate the locomotor frequency. By monitoring fictive locomotion, we compare the facilitatory effects exerted by applying substance P (1 {upsilon}M, 20 min), on the burst frequency before and during application of the endocannabinoid CB1 receptor antagonist AM251 (2-5 {upsilon}M). It is shown that the response to substance P on the burst frequency is significantly reduced during the application of AM251 using two different lamprey species. To examine if endocannabinoids are involved in the substance P mediated modulation of reciprocal inhibition, the commissural axons were stimulated, while recording intracellularly from motoneurons. We compare the effect of substance P on the amplitude of the contralateral compound glycinergic IPSP in control and in the presence of AM251. The blockade of CB1 receptors reduced the substance P mediated decrease in the amplitude by 29%. The present findings suggest that the substance P effect on the increase in the locomotor burst frequency and depression of IPSPs are mediated partially via release of endocannabinoids acting through CB1 receptors.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2009 by the The American Physiological Society.